MoCRA Cosmetic Registration Process in the USA: A Complete 2026 Compliance Guide

The Modernization of Cosmetics Regulation Act — MoCRA — is the most significant reform to US cosmetics law in over 85 years. Signed in December 2022, MoCRA introduced mandatory facility registration, product listing, Responsible Person designation, serious adverse event reporting, and safety substantiation requirements. Deadlines have passed. Non-compliant brands face FDA enforcement action, import alerts, and US distribution disruption.

What Is MoCRA and Why Does It Matter?

Before MoCRA, the FDA had limited authority over cosmetics — no pre-market approval, no mandatory facility registration, no adverse event reporting. MoCRA changed this fundamentally by giving the FDA explicit authority to require registration, listing, recalls, and access to safety records for cosmetic products.

MoCRA compliance applies to every person or entity manufacturing or processing cosmetics for US distribution — regardless of where the facility is located. Foreign manufacturers, importers, private label brands, and contract manufacturers are all within scope.

Who Must Comply With MoCRA?

• Foreign cosmetic manufacturers exporting to the US

• US-based cosmetic manufacturers and contract manufacturers

• Private label brands commissioning cosmetic manufacturing

• Importers who are the Responsible Person for cosmetics entering the US

Facility Registration and Product Listing

Facility Registration

Every cosmetic facility must register with the FDA through FDA Cosmetics Direct. Registration requires: facility name and address, brand names manufactured, cosmetic categories produced, and Responsible Person details. Existing facilities were required to register by December 29, 2023.

Product Listing

Each cosmetic product must be listed with the FDA including the product name, manufacturing facility, cosmetic category, complete INCI ingredient list, and Responsible Person information. Product listings must be updated annually.

Responsible Person Designation

Every cosmetic product must have a designated Responsible Person — the US-based manufacturer, packer, or distributor whose name appears on the label. For foreign manufacturers, the US importer or distributor typically serves in this role. The Responsible Person is legally accountable for FDA compliance, adverse event reporting, and safety records.

Serious Adverse Event Reporting

The Responsible Person must submit a report to the FDA within 15 business days of receiving information about a serious adverse event. A serious adverse event includes any health-related event resulting in death, life-threatening conditions, inpatient hospitalization, persistent disability, congenital anomaly, or any outcome requiring medical or surgical intervention.

MoCRA Compliance Deadlines in 2026

• December 29, 2023 — Facility registration deadline (PASSED)

• December 29, 2023 — Product listing deadline (PASSED)

• December 29, 2024 — Serious adverse event reporting took effect (PASSED)

• Ongoing — Annual product listing renewal required

• Ongoing — 15-business-day window for serious adverse event reports

Labeling Requirements Under MoCRA

All US cosmetics must bear a complete INCI ingredient declaration. A pre-import label compliance review is essential for foreign manufacturers — common labeling violations include non-INCI ingredient names, incorrect order, and missing allergen warnings.

How Axentra Supports MoCRA Compliance

Axentra provides end-to-end MoCRA compliance services: facility registration, product listing, Responsible Person designation, adverse event reporting system setup, and label and INCI ingredient review. Contact us for a free 24-hour expert assessment.